Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2026-01-06 @ 8:55 PM
Study NCT ID:
NCT01342094
Status:
COMPLETED
Last Update Posted:
2015-07-10
First Post:
2011-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
DE-111 Against Timolol Ophthalmic Solution 0.5%
Sponsor:
Santen Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
01111005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None